A. Pini

P21.13 Durvalumab in Locally-Advanced NSCLC in LATAM: Real World Data from Patients Included in the Early Access Program

Florencia Tsou, Martín Ángel, F Reinhold, C. Gabay et autres

ar, us, uy, cl, pr (code pays fourni par la source)

P84.22 Outcomes of TKI Treatment in Patients with NSCLC Harboring Uncommon EGFR Mutations: A Real-World Study in Argentina

Diego Kaen, Florencia Tsou, Lorena Lupinacci, Carmen Puparelli et autres

ar, co (code pays fourni par la source)

Erratum: RENATA study—Latin American prospective experience: clinical outcome of patients treated with palbociclib in hormone receptor-positive metastatic breast cancer—real-world use

Fernando Petracci, Gonzalo Gómez Abuin, A. Pini, Matías Chacón

On page 3, the number 72.5 in the following sentence replaces the number 37.5 which was incorrect: 'The Overall CB was 82.5%, higher in first line than in second line, 85.9% and 62.5%, respectively. The ORR in first line were: 4.7% CR, …

ar (code pays fourni par la source)

RENATA study—Latin American prospective experience: clinical outcome of patients treated with palbociclib in hormone receptor-positive metastatic breast cancer—real-world use

Fernando Petracci, Gonzalo Gómez Abuin, A. Pini, Matías Chacón

BACKGROUND: In hormone receptor-positive, HER-2 negative (HR+/HER2-) advanced breast cancer (ABC) endocrine therapy (ET) plus cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) in first and second line improved progression-free survival (PFS), overall response rate (ORR) and clinical benefit rate (CB) without deterioration in quality …

ar (code pays fourni par la source)

Prevalence of KRAS and NRAS mutations in patients with metastatic colorectal cancer in Argentina: A multicenter prospective observational study.

Gabriela Marechal, Ignacio Casarini, Astegiano Mario Gabriel Gabriel, A. Pini et autres

e15608 Background: Analysis of RAS mutations in specific populations is important as it is a predictive biomarker in the selection of RAS WT patients for treatment with EGFRI(s). There are currently no robust RAS (KRAS and NRAS) mutation data available for Argentinian …

ar, us (code pays fourni par la source)

Periodontal disease prevalence in patients treated with tamoxifen.

Marisa Isabel Brusca, M. Blanco Villalba, Jose Grandinetti, Juan Pablo Re et autres

e11600 Background: Periodontal diseases arise from inflammatory diseases involving the periodontal connective tissue as a common factor. Estrogen produces inflammatory changes that worseness the periodontal preexistent status; and alters the microbiologic environment acting as a nutrient. The objective of this study is …

ar (code pays fourni par la source)

Economic Burden of Costly Cancer Drugs in a Healthcare Service

M. Blanco Villalba, A. Pini, Guillermo Streich, E. Molinas et autres

ar (code pays fourni par la source)

3606 POSTER Incidence of Costly Cancer Treatment in Two Health Care Services

A. Pini, M. Blanco Villalba, Guillermo Streich, Federico Dimase et autres